ALAM
ABBV icon

Asahi Life Asset Management’s AbbVie ABBV Stock Holding History

Asahi Life Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$968K Sell
4,449
-235
-5% -$52.1K 0.63% 37
2025
Q4 		$1.07M Sell
4,684
-463
-9% -$105K 0.6% 34
2025
Q3 		$1.19M Buy
5,147
+352
+7% +$71.7K 0.66% 34
2025
Q2 		$890K Buy
4,795
+2,975
+163% +$553K 0.52% 41
2025
Q1 		$381K Sell
1,820
-3,470
-66% -$675K 0.25% 103
2024
Q4 		$940K Buy
5,290
+1,090
+26% +$200K 0.57% 35
2024
Q3 		$829K Sell
4,200
-1,250
-23% -$233K 0.5% 39
2024
Q2 		$935K Buy
5,450
+3,450
+173% +$571K 0.64% 33
2024
Q1 		$364K Sell
2,000
-3,865
-66% -$666K 0.22% 112
2023
Q4 		$909K Buy
5,865
+3,790
+183% +$553K 0.49% 36
2023
Q3 		$309K Sell
2,075
-1,905
-48% -$280K 0.11% 116
2023
Q2 		$536K Sell
3,980
-2,020
-34% -$296K 0.18% 62
2023
Q1 		$956K Sell
6,000
-125
-2% -$19.1K 0.3% 49
2022
Q4 		$990K Sell
6,125
-270
-4% -$41.4K 0.33% 47
2022
Q3 		$858K Buy
6,395
+55
+0.9% +$7.89K 0.27% 44
2022
Q2 		$971K Sell
6,340
-790
-11% -$121K 0.26% 46
2022
Q1 		$1.16M Sell
7,130
-720
-9% -$105K 0.16% 46
2021
Q4 		$1.06M Sell
7,850
-60
-0.8% -$7.09K 0.13% 46
2021
Q3 		$853K Sell
7,910
-70
-0.9% -$8K 0.12% 51
2021
Q2 		$899K Sell
7,980
-550
-6% -$61.9K 0.12% 46
2021
Q1 		$923K Buy
8,530
+5,770
+209% +$617K 0.13% 47
2020
Q4 		$296K Sell
2,760
-1,790
-39% -$172K 0.04% 182
2020
Q3 		$399K Sell
4,550
-310
-6% -$29.2K 0.06% 101
2020
Q2 		$477K Buy
4,860
+3,170
+188% +$279K 0.08% 68
2020
Q1 		$129K Sell
1,690
-7,790
-82% -$664K 0.02% 179
2019
Q4 		$839K Sell
9,480
-730
-7% -$60.6K 0.12% 47
2019
Q3 		$773K Buy
10,210
+1,410
+16% +$96.7K 0.13% 48
2019
Q2 		$640K Buy
8,800
+6,240
+244% +$490K 0.13% 59
2019
Q1 		$206K Sell
2,560
-8,670
-77% -$709K 0.03% 165
2018
Q4 		$1.03M Buy
+11,230
New +$988K 0.16% 42

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Asahi Life Asset Management's ABBV Position: Q1 2026 in Review

Asahi Life Asset Management reduced its AbbVie (ABBV) stake by 5% in Q1 2026, selling an estimated $52.1K and leaving 4,449 shares worth $968K. The position accounts for 0.63% of the portfolio, ranked #37.

Asahi Life Asset Management first reported a position in ABBV in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.19M in Q3 2025. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Asahi Life Asset Management held 4,449 shares of AbbVie worth $968K as of Q1 2026.
  • Asahi Life Asset Management sold 235 AbbVie shares in Q1 2026, an estimated $52.1K.
  • AbbVie made up 0.63% of Asahi Life Asset Management's portfolio in Q1 2026, its #37 holding.
  • Asahi Life Asset Management first reported a position in AbbVie in Q4 2018 and has held it in 30 quarters since.
  • Asahi Life Asset Management's AbbVie position peaked at $1.19M in Q3 2025.
  • 4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Asahi Life Asset Management's 13F filing for Q1 2026, filed 27 Apr 2026.